Literature DB >> 11935336

A candidate gene for congenital bilateral isolated ptosis identified by molecular analysis of a de novo balanced translocation.

Tristan W McMullan1, John A Crolla, Simon G Gregory, Nigel P Carter, Rachel A Cooper, Gareth R Howell, David O Robinson.   

Abstract

Ptosis is defined as drooping of the upper eyelid and can impair full visual acuity. It occurs in a number of forms including congenital bilateral isolated ptosis, which may be familial and for which two linkage groups are known on chromosomes 1p32-34.1 and Xq24-27.1. We describe the analysis of the chromosome breakpoints in a patient with congenital bilateral isolated ptosis and a de novo balanced translocation 46,XY,t(1;8)(p34.3;q21.12). Both breakpoints were localized by fluorescence in situ hybridisation with yeast artificial chromosomes, bacterial artificial chromosomes and P1 artificial chromosomes. The derived chromosomes were isolated by flow-sorting, amplified by degenerate oligonucleotide-primed polymerase chain reaction and analyzed by sequence tagged sites amplification to map the breakpoints at a resolution that enabled molecular characterization by DNA sequencing. The 1p breakpoint lies ~13 Mb distal to the previously reported linkage locus at 1p32-1p34.1 and does not disrupt a coding sequence, whereas the chromosome 8 breakpoint disrupts a gene homologous to the mouse zfh-4gene. Murine zfh-4 codes for a zinc finger homeodomain protein and is a transcription factor expressed in both muscle and nerve tissue. Human ZFH-4 is therefore a candidate gene for congenital bilateral isolated ptosis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11935336     DOI: 10.1007/s00439-002-0679-5

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  25 in total

1.  Array painting: a method for the rapid analysis of aberrant chromosomes using DNA microarrays.

Authors:  H Fiegler; S M Gribble; D C Burford; P Carr; E Prigmore; K M Porter; S Clegg; J A Crolla; N R Dennis; P Jacobs; N P Carter
Journal:  J Med Genet       Date:  2003-09       Impact factor: 6.318

2.  Ultra-high resolution array painting facilitates breakpoint sequencing.

Authors:  S M Gribble; D Kalaitzopoulos; D C Burford; E Prigmore; R R Selzer; B L Ng; N S W Matthews; K M Porter; R Curley; S J Lindsay; J Baptista; T A Richmond; N P Carter
Journal:  J Med Genet       Date:  2006-09-13       Impact factor: 6.318

3.  The complex nature of constitutional de novo apparently balanced translocations in patients presenting with abnormal phenotypes.

Authors:  S M Gribble; E Prigmore; D C Burford; K M Porter; Bee Ling Ng; E J Douglas; H Fiegler; P Carr; D Kalaitzopoulos; S Clegg; R Sandstrom; I K Temple; S A Youings; N S Thomas; N R Dennis; P A Jacobs; J A Crolla; N P Carter
Journal:  J Med Genet       Date:  2005-01       Impact factor: 6.318

4.  Identification of sequence motifs at the breakpoint junctions in three t(1;9)(p36.3;q34) and delineation of mechanisms involved in generating balanced translocations.

Authors:  Marzena Gajecka; Adam Pavlicek; Caron D Glotzbach; Blake C Ballif; Malgorzata Jarmuz; Jerzy Jurka; Lisa G Shaffer
Journal:  Hum Genet       Date:  2006-07-18       Impact factor: 4.132

5.  Breakpoint mapping and array CGH in translocations: comparison of a phenotypically normal and an abnormal cohort.

Authors:  Julia Baptista; Catherine Mercer; Elena Prigmore; Susan M Gribble; Nigel P Carter; Viv Maloney; N Simon Thomas; Patricia A Jacobs; John A Crolla
Journal:  Am J Hum Genet       Date:  2008-03-27       Impact factor: 11.025

6.  ZFHX4 interacts with the NuRD core member CHD4 and regulates the glioblastoma tumor-initiating cell state.

Authors:  Yakov Chudnovsky; Dohoon Kim; Siyuan Zheng; Warren A Whyte; Mukesh Bansal; Mark-Anthony Bray; Shuba Gopal; Matthew A Theisen; Steve Bilodeau; Prathapan Thiru; Julien Muffat; Omer H Yilmaz; Maya Mitalipova; Kevin Woolard; Jeongwu Lee; Riko Nishimura; Nobuo Sakata; Howard A Fine; Anne E Carpenter; Serena J Silver; Roel G W Verhaak; Andrea Califano; Richard A Young; Keith L Ligon; Ingo K Mellinghoff; David E Root; David M Sabatini; William C Hahn; Milan G Chheda
Journal:  Cell Rep       Date:  2014-01-16       Impact factor: 9.423

7.  Characterization of a 8q21.11 microdeletion syndrome associated with intellectual disability and a recognizable phenotype.

Authors:  María Palomares; Alicia Delicado; Elena Mansilla; María Luisa de Torres; Elena Vallespín; Luis Fernandez; Victor Martinez-Glez; Sixto García-Miñaur; Julián Nevado; Fernando Santos Simarro; Victor L Ruiz-Perez; Sally Ann Lynch; Freddie H Sharkey; Ann-Charlotte Thuresson; Göran Annerén; Elga F Belligni; María Luisa Martínez-Fernández; Eva Bermejo; Beata Nowakowska; Anna Kutkowska-Kazmierczak; Ewa Bocian; Ewa Obersztyn; María Luisa Martínez-Frías; Raoul C M Hennekam; Pablo Lapunzina
Journal:  Am J Hum Genet       Date:  2011-07-28       Impact factor: 11.025

8.  Genome-wide linkage analysis and mutation analysis of hereditary congenital blepharoptosis in a Japanese family.

Authors:  Mitsuko Nakashima; Motoi Nakano; Akiyoshi Hirano; Tatsuya Kishino; Shinji Kondoh; Nobutomo Miwa; Norio Niikawa; Koh-Ichiro Yoshiura
Journal:  J Hum Genet       Date:  2007-11-07       Impact factor: 3.172

9.  Current techniques in surgical correction of congenital ptosis.

Authors:  Felicia D Allard; Vikram D Durairaj
Journal:  Middle East Afr J Ophthalmol       Date:  2010-04

10.  The role of apoptosis in blepharoptosis.

Authors:  E Şahlı; B M Hoşal; G Zilelioğlu; N Dinçer; G G Tezel
Journal:  Eye (Lond)       Date:  2013-04-19       Impact factor: 3.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.